IDEAYA Biosciences Announces Submission of IND Application to the U S FDA for PARG Development Candidate IDE161

Monday, December 12, 2022 1 min read

Key Takeaway: IDEAYA Biosciences Announces Submission of IND Application to the U S FDA for PARG Development Candidate IDE161

Full Press Release Details

IDEAYA Biosciences Announces Submission of IND Application to the U S FDA for PARG Development Candidate IDE161.